Skip to main content

INOmax (Ikaria Australia Pty Ltd)

Product name
INOmax
Date registered
Evaluation commenced
Decision date
Approval time
208 working days (255)
Active ingredients
nitric oxide
Registration type
EOI
Indication

INOmax (medicinal gas for inhalation) in conjunction with ventilatory support and other appropriate agents, is now also indicated to selectively decrease pulmonary arterial pressure in patients with perioperative pulmonary hypertension in conjunction with heart surgery.

Help us improve the Therapeutic Goods Administration site